InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,634.61
(
1.15%
)
US TECH 100
19,209.60
(
0.05%
)
Dow Jones
41,175.08
(
1.14%
)
Brent Oil
80.11
(
2.21%
)
Bitcoin
63,970.58
(
-0.60%
)

Replies to post #90754 on Biotech Values

Replies to #90754 on Biotech Values
icon url

DewDiligence

02/18/10 9:37 AM

#90755 RE: genisi #90754

Neurontin was a multi-billion dollar drug for PFE before it went generic in 2004. Thus, one would presume that the safety issue in question ought to be well characterized.
icon url

turtlepower

02/18/10 11:40 AM

#90760 RE: genisi #90754

The rejection may be related to the REMS that was submitted last year not being adequately strong.